Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
In neonatal mice, low or moderate cortical activity has no effect on the developing cerebral microvasculature, but more-persistent, repetitive cortical activity can lead to detrimental changes in the cerebral microvasculature.
A study involving a mouse model of autism shows that gut microbes and gastrointestinal abnormalities influence behaviour and suggests that targeting the gut microbiome may alleviate some of the behavioural symptoms of neurodevelopmental disorders.
MicroRNA-128 is expressed in striatal dopamine D1 receptor-expressing neurons and might contribute to the neuronal hyperexcitability observed in epilepsy and motor disorders such as Parkinson's disease.
Cyclooxygenase 2 inhibitors could be used to prevent at least some of the unwanted side effects of the marijuana component Δ9-THC without impairing its beneficial properties.
Two new studies reveal that parvalbumin-expressing interneurons form extensive connections with mitral cells and tufted cells in the olfactory bulb and have an important role in odour processing.
Neural progenitor cell (NPC) profileration in mice is associated with oscillating patterns of expression of several transcription factors, whereas NPC differentiation is associated with the sustained, dominant expression of particular transcription factors.
Two recent studies show that vasoactive intestinal polypeptide-expressing interneurons exert a disinhibitory effect on cortical pyramidal cells in a number of brain areas, and this has important implications for control of cortical processing and behaviour.
Acute inflammatory pain can result in long-lasting central sensitization of spinal nociceptive pathways that is masked by upregulation of endogenous opioid signalling via the μ-opioid receptor.